期刊文献+

Notch3受体在非小细胞肺癌中的表达 被引量:1

Immunohistochemical Detection of Notch3 Expression in Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的研究Notch3受体在非小细胞肺癌(NSCLC)组织中的表达情况,探讨Notch3受体与NSCLC发病的相关性。方法外科手术切除后由病理确诊为NSCLC 80例患者(临床病理资料完整,术前未经放、化疗及其他抗肿瘤治疗)的肺癌组织,40例正常肺组织(为癌旁距离肿块边缘5 cm以上、经病理HE染色证实为正常的肺组织),免疫组织化学SP法检测肺癌组织及癌旁正常肺组织中Notch3受体的表达。结果 NSCLC肺组织中Notch3受体水平明显高于对照组(χ~2=19.937,P<0.01); Notch3受体水平与患者性别,年龄,组织类型(肺腺、鳞癌)无相关性(P>0. 05); TNMⅢ+Ⅳ期中Notch3受体水平阳性率为73.3%,TNMⅠ+Ⅱ期阳性率为44.0%,差异有统计学意义(χ~2=6. 519,P<0. 05);有淋巴结转移患者的Notch3受体阳性表达率为84.2%,无淋巴结转移患者的阳性率为28.6%,差异有统计学意义(χ~2=24. 953,P<0.05)。结论 Notch3受体的表达水平与NSCLC的TNM分期、淋巴结转移密切相关,Notch3受体参与了NSCLC的发病及进展,对NSCLC患者的疾病进展及预后有重要意义;同时,阻断其表达有望成为NSCLC靶向治疗的新靶点。 Objective To investigate the expression of Notch3 receptor in non-small cell lung cancer tissues,and explore the role of Notch3 receptor in the pathogenesis of non-small cell lung cancer.Methods80 patients with lung cancer tissues diagnosed as non-small cell lung cancer after surgical resection( complete clinical and pathological data,without preoperative radiotherapy,chemotherapy and other antitumor treatment) and 40 normal lung tissues were selected. The expression of Notch3 receptor in lung cancer tissues and adjacent normal lung tissues was detected by immunohistochemical SP method.Results The positive expression rate of Notch3 receptor in non-small cell lung cancer tissues( 55.0%) was significantly higher than that in adjacent normal lung tissues( expressive rate was 12. 5%,P < 0. 01) and the difference was statistically significant.The positive expression rate of Notch3 receptor in TNM Ⅲ+Ⅳ stage of non-small cell lung cancer( 73.3%) was significantly higher than that of TNM Ⅰ+Ⅱ stage( expression rate was 44.0%,P<0.05) and the difference was statistically significant.The positive expression rate of Notch3 receptor in patients with lymph node metastasis of non-small cell lung cancer( 84.21%) was significantly higher than that of patients without lymph node metastasis( express rate was 28. 57%,P <0. 05) and the difference was statistically significant.Conclusion The expression level of Notch3 receptor is closely related to TNM stage and lymph node metastasis of non-small cell lung cancer.Notch3 receptor is involved in the pathogenesis and progression of non-small cell lung cancer,and it is important for the disease progression and prognosis of patients with non-small cell lung cancer.At the same time,blocking its expression is expected to become a new target for targeted therapy of non-small cell lung cancer.
作者 魏煜 赵蕴伟 李树民 梁姗姗 王春玲 姚伟英 Wei Yu;Zhao Yunwei;Li Shumin;Liang Shanshan;Wang Chunling;Yao Weiying(Jiamusi University,Jiamusi 154007,China;The First Affiliated Hospital of Jiamusi University,Jiamusi 154002,China;The Jiamusi Central Hospital,Jiamusi 154007,China)
出处 《湖北民族学院学报(医学版)》 2019年第1期31-34,共4页 Journal of Hubei Minzu University(Medical Edition)
基金 黑龙江省卫生计生委科研课题(2018-181)
关键词 非小细胞肺癌 Notch3受体 NOTCH信号通路 免疫组化 non-small cell lung cancer Notch3 receptor Notch signaling pathway immunohistochemistry
  • 相关文献

参考文献1

二级参考文献10

  • 1郑莺凤,郑志竑.Notch与Ras/MAPK信号通路在胚胎发育及肿瘤发生中的串话[J].医学分子生物学杂志,2006,3(6):460-463. 被引量:4
  • 2姜昕,周建华.Notch信号通路及其在肺癌发生中的作用[J].国际病理科学与临床杂志,2007,27(3):231-234. 被引量:11
  • 3Lai EC. Notch signaling:control of cell communication and cell fata [J]. Development,2004 ; 131 ( 5 ) :965-73.
  • 4Zheng Q J, Qin HY, Zhang HW, et al. Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549 [ J]. Oncology Reports, 2007 ; 17:847-52.
  • 5Chen H ,Thiagalingam A, Chopra H, et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein ( HES-1 ) directly represses achaete-scute homolog-1 expression[ J]. Proc Natl Acad Sci USA, 1997 ;94:5355450.
  • 6Eliasz S, Liang S, Chen Y,et al. Notch-1 stimulates survival of lung ade- nocarcinoma cells during hypoxia by activating the IGF-1R pathway [ J]. Oncogene ,2010 ;29( 17 ) :2488-98.
  • 7Martinez A, Zecchini V, Brennan K. CSL-independent Notch signaling: a checkpoint in cell fate decisions during development [ J ]. Curr Opin Genet Dev ,2002 ; 12 (5) :524-33.
  • 8Shih IM, Wang TL Notch signaling, γ-seeretase inhibitors, and cancer therapy [ J ]. Cancer Res,2007 ;67 ( 5 ) : 1879 -82.
  • 9Haruki N,Kawaguchi KS,Eichenberger S,et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers [ J]. Cancer Res ,2005 ;65 (9) :3555-61.
  • 10Westhoff B, Colaluca IN, D'Ario G, et al. Alterations of the Notch path- way in lung cancer[ J). Proc Natl Acad Sci USA,2009; 106 (52): 22293-8.

共引文献5

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部